Product Pipeline

(As of September 2023)

Development Pipelines

Product code Target Indication Dosage Form Development region Current Phase
M5250 Pruritus with atopic dermatitis (pediatric) Injection JP Filed for Approval
M5250B Prurigo nodularis Injection JP Filed for Approval
M5250E Pruritus with atopic dermatitis
(infant)
Injection JP PIII
M6050C Acne vulgaris Topical JP PIII
M6100 Atopic dermatitis Topical JP PIII
M6050F Axillary osmidrosis Topical JP PII